問題一覧
1
disruption of function
2
hematologic alterations
3
paraneoplastic syndrome
4
adrenocorticotropic hormone
5
pain
6
physical stress
7
– Change in bowel or bladder habits – A sore that does not heal – Unusual bleeding or discharge – Thickenings or lumps – Indigestion or difficulty in swallowing – Obvious change in a wart or mole – Nagging or persistent cough or hoarseness – Unexplained anemia – Sudden unexplained weight loss
8
inspection, palpation, auscultation
9
– Complete blood cell count (CBC) – Tumor markers – identify substance (specific proteins) in the blood that are made by the tumor • PSA (Prostatic-specific antigen): prostate cancer • CEA (Carcinoembryonic antigen): colon cancer • Alkaline Phosphatase: bone metastasis
10
PSA (Prostatic-specific antigen)
11
CEA (Carcinoembryonic antigen)
12
Alkaline Phosphatase
13
primary, secondary, tertiary prevention
14
primary prevention
15
secondary prevention
16
tertiary prevention
17
cure control palliation
18
cure
19
control
20
palliation
21
surgery
22
1. Treat the primary cancer 2.To remove isolated metastatic masses 3.To make other methods of treatment possible 4. Diagnosis and Staging 5. Reconstruct anatomical defects to improve function, cosmetic appearance, and quality of life 6. Prevention 7. Treat complication 8. Debulking 9. Surgical removal of a source of hormone
23
1. Diagnostic Surgery 2. Prophylactic Surgery 3. Palliative Surgery 4. Reconstructive Surgery
24
radiation therapy
25
neoadjuvant therapy
26
palliative radiation therapy
27
to cure cancer, to reduce symptoms
28
externally, internally
29
external radiation therapy
30
EBRT -external beam radiation therapy
31
three-dimensional conformal radiation therapy (3D-CRT)
32
intensity modulated radiation therapy (IMRT)
33
proton beam therapy
34
neutron beam therapy
35
stereotactic radiotherapy
36
stereotactic radiosurgery
37
internal radiation therapy
38
sealed source, unsealed source
39
sealed source
40
intracavity rt
41
interstitial therapy
42
unsealed source
43
distance, time, shielding
44
3 feet
45
radiation dosimeter badge
46
skin reactions, infection, hemorrhage, fatigue, weight loss, stomatitis and xerostomia, diarrhea nausea and vomiting headache alopecia cystitis, social isolation
47
three-dimensional conformal radiation therapy intensity modulated radiation therapy proton beam therapy neutron beam therapy stereotactic radiotherapy
MPLE
MPLE
ユーザ名非公開 · 41問 · 13日前MPLE
MPLE
41問 • 13日前Weekly Test 2
Weekly Test 2
ユーザ名非公開 · 50問 · 13日前Weekly Test 2
Weekly Test 2
50問 • 13日前Definition of Terms 2
Definition of Terms 2
ユーザ名非公開 · 90問 · 13日前Definition of Terms 2
Definition of Terms 2
90問 • 13日前Definition of Terms 1
Definition of Terms 1
ユーザ名非公開 · 90問 · 13日前Definition of Terms 1
Definition of Terms 1
90問 • 13日前SPI version D pt 2
SPI version D pt 2
ユーザ名非公開 · 61問 · 13日前SPI version D pt 2
SPI version D pt 2
61問 • 13日前RNPCP Chapter 10 to 13
RNPCP Chapter 10 to 13
ユーザ名非公開 · 93問 · 13日前RNPCP Chapter 10 to 13
RNPCP Chapter 10 to 13
93問 • 13日前RNPCP Chapter 6 to 9
RNPCP Chapter 6 to 9
ユーザ名非公開 · 94問 · 13日前RNPCP Chapter 6 to 9
RNPCP Chapter 6 to 9
94問 • 13日前Practical Problems and Experiences REFRESHER 2
Practical Problems and Experiences REFRESHER 2
ユーザ名非公開 · 70問 · 13日前Practical Problems and Experiences REFRESHER 2
Practical Problems and Experiences REFRESHER 2
70問 • 13日前August 2019 Special PE Exam
August 2019 Special PE Exam
ユーザ名非公開 · 93問 · 13日前August 2019 Special PE Exam
August 2019 Special PE Exam
93問 • 13日前July 2023 PE Refresher
July 2023 PE Refresher
ユーザ名非公開 · 70問 · 13日前July 2023 PE Refresher
July 2023 PE Refresher
70問 • 13日前単位認定試験 生物基礎
単位認定試験 生物基礎
ユーザ名非公開 · 45問 · 1ヶ月前単位認定試験 生物基礎
単位認定試験 生物基礎
45問 • 1ヶ月前M#3
M#3
ユーザ名非公開 · 58問 · 1ヶ月前M#3
M#3
58問 • 1ヶ月前ap psych midterm 1.1-1.4
ap psych midterm 1.1-1.4
ユーザ名非公開 · 63問 · 1ヶ月前ap psych midterm 1.1-1.4
ap psych midterm 1.1-1.4
63問 • 1ヶ月前ENZYME OF CLINICAL SIGNIFICANCE-MCQ2
ENZYME OF CLINICAL SIGNIFICANCE-MCQ2
ayrika · 87問 · 1ヶ月前ENZYME OF CLINICAL SIGNIFICANCE-MCQ2
ENZYME OF CLINICAL SIGNIFICANCE-MCQ2
87問 • 1ヶ月前ENZYME OF CLINICAL SIGNIFICANCE-MCQ
ENZYME OF CLINICAL SIGNIFICANCE-MCQ
ayrika · 99問 · 1ヶ月前ENZYME OF CLINICAL SIGNIFICANCE-MCQ
ENZYME OF CLINICAL SIGNIFICANCE-MCQ
99問 • 1ヶ月前FACTORS AFFECTING ENZYME ACTIVITY-MCQ
FACTORS AFFECTING ENZYME ACTIVITY-MCQ
ayrika · 89問 · 1ヶ月前FACTORS AFFECTING ENZYME ACTIVITY-MCQ
FACTORS AFFECTING ENZYME ACTIVITY-MCQ
89問 • 1ヶ月前CLASS AND VARIANT OF ENZYME-MCQ
CLASS AND VARIANT OF ENZYME-MCQ
ayrika · 77問 · 1ヶ月前CLASS AND VARIANT OF ENZYME-MCQ
CLASS AND VARIANT OF ENZYME-MCQ
77問 • 1ヶ月前INTRODUCTION TO ENZYMOLOGY-MCQ
INTRODUCTION TO ENZYMOLOGY-MCQ
ayrika · 41問 · 1ヶ月前INTRODUCTION TO ENZYMOLOGY-MCQ
INTRODUCTION TO ENZYMOLOGY-MCQ
41問 • 1ヶ月前TDM
TDM
ayrika · 94問 · 1ヶ月前TDM
TDM
94問 • 1ヶ月前TDM
TDM
ayrika · 94問 · 1ヶ月前TDM
TDM
94問 • 1ヶ月前問題一覧
1
disruption of function
2
hematologic alterations
3
paraneoplastic syndrome
4
adrenocorticotropic hormone
5
pain
6
physical stress
7
– Change in bowel or bladder habits – A sore that does not heal – Unusual bleeding or discharge – Thickenings or lumps – Indigestion or difficulty in swallowing – Obvious change in a wart or mole – Nagging or persistent cough or hoarseness – Unexplained anemia – Sudden unexplained weight loss
8
inspection, palpation, auscultation
9
– Complete blood cell count (CBC) – Tumor markers – identify substance (specific proteins) in the blood that are made by the tumor • PSA (Prostatic-specific antigen): prostate cancer • CEA (Carcinoembryonic antigen): colon cancer • Alkaline Phosphatase: bone metastasis
10
PSA (Prostatic-specific antigen)
11
CEA (Carcinoembryonic antigen)
12
Alkaline Phosphatase
13
primary, secondary, tertiary prevention
14
primary prevention
15
secondary prevention
16
tertiary prevention
17
cure control palliation
18
cure
19
control
20
palliation
21
surgery
22
1. Treat the primary cancer 2.To remove isolated metastatic masses 3.To make other methods of treatment possible 4. Diagnosis and Staging 5. Reconstruct anatomical defects to improve function, cosmetic appearance, and quality of life 6. Prevention 7. Treat complication 8. Debulking 9. Surgical removal of a source of hormone
23
1. Diagnostic Surgery 2. Prophylactic Surgery 3. Palliative Surgery 4. Reconstructive Surgery
24
radiation therapy
25
neoadjuvant therapy
26
palliative radiation therapy
27
to cure cancer, to reduce symptoms
28
externally, internally
29
external radiation therapy
30
EBRT -external beam radiation therapy
31
three-dimensional conformal radiation therapy (3D-CRT)
32
intensity modulated radiation therapy (IMRT)
33
proton beam therapy
34
neutron beam therapy
35
stereotactic radiotherapy
36
stereotactic radiosurgery
37
internal radiation therapy
38
sealed source, unsealed source
39
sealed source
40
intracavity rt
41
interstitial therapy
42
unsealed source
43
distance, time, shielding
44
3 feet
45
radiation dosimeter badge
46
skin reactions, infection, hemorrhage, fatigue, weight loss, stomatitis and xerostomia, diarrhea nausea and vomiting headache alopecia cystitis, social isolation
47
three-dimensional conformal radiation therapy intensity modulated radiation therapy proton beam therapy neutron beam therapy stereotactic radiotherapy